ClinicalTrials.gov
public full text
Public Domain
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
To learn if giving tivozanib in combination with nivolumab can help to control advanced nccRCC.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)#1045604
- Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)#28459
- A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma#911182
- Nivolumab Plus Metformin in Metastatic Renal Cell Carcinoma#283211
- Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma#900512
Record · ID 869797
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive